Perfil
Robert S.
Goodenow held several positions in the pharmaceutical industry, including Principal at Baxter International, Head-Oncology Business Development at Aventis, Secretary & Chief Business Officer at Syndax Pharmaceuticals, and Chief Business Officer at HUYA Bioscience International LLC.
He also served as Vice President-Corporate Development at Inovio Pharmaceuticals, Inc. from 2002 to 2007.
Goodenow received a doctorate from Stanford University and an undergraduate degree from the University of California, Berkeley.
Antiguos cargos conocidos de Robert Goodenow.
Empresas | Cargo | Fin |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 16/03/2007 |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Presidente | - |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - |
Aventis, Inc. | Corporate Officer/Principal | - |
SYNDAX PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Robert Goodenow.
University of California, Berkeley | Undergraduate Degree |
Stanford University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
INOVIO PHARMACEUTICALS, INC. | Health Technology |
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Aventis, Inc. | |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Goodenow